GlassScriptPhysician profile
Gila Leiter
NPI 1881783306
$3,857.42
in general payments reported to CMS, 2019-2025
34 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $802 · 2020: $272 · 2021: $415 · 2022: $669 · 2023: $807 · 2024: $607 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,674 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.60 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $461.93 | 2019-2024 | Prolia, Evenity |
| Millicent US INC | $291.15 | 2019-2025 | Intrarosa, Femlyv |
| Evofem Biosciences, INC. | $263.42 | 2021-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $237.01 | 2020-2025 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Pfizer INC. | $233.03 | 2019-2024 | |
| Abbvie INC. | $224.85 | 2019-2023 | |
| Shield Therapeutics INC | $218.23 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $206.92 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $205.74 | 2019-2021 | |
| Exact Sciences Corporation | $187.92 | 2023-2025 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $180.77 | 2022-2024 | |
| Vertical Pharmaceuticals, LLC | $137.54 | 2019 | |
| Exeltis, USA INC. | $129.15 | 2019-2020 | |
| Avion Pharmaceuticals | $115.30 | 2019-2022 | |
| Scynexis, INC. | $101.82 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $65.82 | 2021-2022 | |
| Myovant Sciences INC. | $63.11 | 2022 | |
| Sumitomo Pharma America, INC. | $61.49 | 2023-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $54.89 | 2020-2022 | |
| Organon LLC | $51.67 | 2022-2023 | Nexplanon |
| Amag Pharmaceuticals, INC. | $49.97 | 2019-2020 | |
| Ibsa Pharma INC. | $48.27 | 2023 | Tirosint, Licart |
| Daiichi Sankyo INC. | $39.09 | 2022-2024 | Injectafer |
| Renovia INC | $33.55 | 2019 | |
| Aspira Women'S Health INC | $32.34 | 2022 | |
| Virtus Pharmaceuticals LLC | $31.63 | 2022 | |
| Duchesnay USA Incorporated | $22.14 | 2019 | |
| Glaxosmithkline, LLC. | $18.73 | 2021 | |
| Celularity INC. | $18.00 | 2019 | |
| Mission Pharmacal Company | $16.43 | 2019 | |
| Biogen, INC. | $15.08 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $14.62 | 2024 | Paragard T 380a |
| Dysis Medical, INC. | $14.53 | 2021 | |
| Allergan, INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gila Leiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.